Stay updated on High-Dose Eteplirsen in DMD Clinical Trial
Sign up to get notified when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.

Latest updates to the High-Dose Eteplirsen in DMD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedIndividual location subsections (Alabama Locations, Florida Locations, Georgia Locations, Attica Locations, Sinaloa Locations, Pomeranian Voivodeship Locations, West Yorkshire Locations) were removed and replaced with a consolidated 'Locations' section listing those areas. The page revision tag updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure entry was removed.SummaryDifference0.6%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing v3.2.0. No changes to study details or page structure are evident; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedDeleted the government funding status notice. The study's essential details and sections on the page remain unchanged.SummaryDifference0.2%

- Check76 days agoChange DetectedTwo screenshots show no changes to core study details; observed differences are minor formatting and layout adjustments that do not affect the page's purpose. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check97 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference3%

- Check105 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.1%

Stay in the know with updates to High-Dose Eteplirsen in DMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.